Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium ulcerans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 26.9 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Candida albicans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 358 aa | 22.6 % |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 25.8 % |
Candida albicans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 358 aa | 22.6 % |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 25.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | geminin | 0.0171 | 0.3456 | 0.3599 |
Echinococcus granulosus | tankyrase | 0.0032 | 0.0207 | 0.0215 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.2831 | 0.3943 |
Echinococcus granulosus | poly (ADP ribose) polymerase | 0.0067 | 0.103 | 0.1073 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 0.3456 | 0.3599 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0779 | 0.1085 |
Onchocerca volvulus | 0.0058 | 0.0818 | 1 | |
Brugia malayi | hypothetical protein | 0.0286 | 0.6143 | 0.6397 |
Entamoeba histolytica | hypothetical protein | 0.0032 | 0.0207 | 0.0215 |
Brugia malayi | WGR domain containing protein | 0.0433 | 0.9603 | 1 |
Entamoeba histolytica | zinc finger protein, putative | 0.0032 | 0.0207 | 0.0215 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.6143 | 0.6397 |
Schistosoma mansoni | poly [ADP-ribose] polymerase | 0.0206 | 0.4277 | 0.4454 |
Echinococcus multilocularis | geminin | 0.0171 | 0.3456 | 0.3599 |
Entamoeba histolytica | hypothetical protein | 0.0032 | 0.0207 | 0.0215 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.0631 | 0.0658 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0818 | 0.0852 |
Schistosoma mansoni | poly [ADP-ribose] polymerase | 0.0238 | 0.503 | 0.5238 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0057 | 0.0779 | 1 |
Brugia malayi | Tnks protein | 0.0032 | 0.0207 | 0.0215 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.0631 | 0.088 |
Echinococcus granulosus | poly (ADP ribose) polymerase | 0.0135 | 0.2606 | 0.2714 |
Trypanosoma brucei | poly(adp-ribose) polymerase | 0.0238 | 0.503 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.0631 | 0.0658 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0259 | 0.027 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Echinococcus granulosus | WGR domain containing protein | 0.0135 | 0.2606 | 0.2714 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0172 | 0.3492 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 1 |
Echinococcus multilocularis | poly (ADP ribose) polymerase 1 | 0.0433 | 0.9603 | 1 |
Echinococcus multilocularis | poly (ADP ribose) polymerase | 0.0099 | 0.1783 | 0.1857 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 0.804 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.2831 | 0.3943 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.6143 | 0.8556 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Loa Loa (eye worm) | tnks protein | 0.0032 | 0.0207 | 0.0288 |
Entamoeba histolytica | hypothetical protein | 0.0032 | 0.0207 | 0.0215 |
Echinococcus granulosus | poly ADP ribose polymerase 1 | 0.0433 | 0.9603 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0259 | 0.027 |
Echinococcus multilocularis | tankyrase | 0.0032 | 0.0207 | 0.0215 |
Leishmania major | DNA repair protein, putative | 0.0057 | 0.0779 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 0.3456 | 0.3599 |
Trypanosoma cruzi | Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region/Zinc-finger (CX5CX6HX5H) motif containing protein, putative | 0.0057 | 0.0779 | 0.1549 |
Echinococcus multilocularis | poly (adp ribose) polymerase 2 | 0.0238 | 0.503 | 0.5238 |
Echinococcus granulosus | poly adp ribose polymerase 2 | 0.0238 | 0.503 | 0.5238 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Loa Loa (eye worm) | hypothetical protein | 0.033 | 0.7179 | 1 |
Loa Loa (eye worm) | poly(ADP-ribose) polymerase | 0.0171 | 0.3454 | 0.481 |
Entamoeba histolytica | poly(ADP-ribose) polymerase, putative | 0.0433 | 0.9603 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 1 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0172 | 0.3492 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.2831 | 0.2948 |
Entamoeba histolytica | hypothetical protein | 0.0067 | 0.103 | 0.1073 |
Trypanosoma cruzi | poly(ADP-ribose) polymerase, putative | 0.0238 | 0.503 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0631 | 0.088 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0818 | 0.0852 |
Trypanosoma brucei | Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region/Zinc-finger (CX5CX6HX5H) motif containing protein, putative | 0.0057 | 0.0779 | 0.1549 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 1 |
Echinococcus granulosus | poly (ADP ribose) polymerase | 0.0067 | 0.103 | 0.1073 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0259 | 0.0361 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0172 | 0.3492 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0353 | 0.7721 | 0.5 |
Trypanosoma cruzi | poly(ADP-ribose) polymerase, putative | 0.0238 | 0.503 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.6143 | 0.6397 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0032 | 0.0207 | 0.0268 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 0.804 |
Brugia malayi | WGR domain containing protein | 0.0238 | 0.503 | 0.5238 |
Onchocerca volvulus | DNA ligase 3 homolog | 0.0057 | 0.0779 | 0.9359 |
Loa Loa (eye worm) | hypothetical protein | 0.0238 | 0.503 | 0.7006 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0818 | 0.0852 |
Trypanosoma brucei | DNA repair protein, putative | 0.0057 | 0.0779 | 0.1549 |
Entamoeba histolytica | hypothetical protein | 0.0032 | 0.0207 | 0.0215 |
Schistosoma mansoni | tankyrase | 0.0032 | 0.0207 | 0.0215 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.7721 | 1 |
Echinococcus granulosus | poly (ADP ribose) polymerase | 0.0067 | 0.103 | 0.1073 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0353 | 0.7721 | 1 |
Schistosoma mansoni | poly [ADP-ribose] polymerase | 0.0433 | 0.9603 | 1 |
Trypanosoma cruzi | DNA repair protein, putative | 0.0057 | 0.0779 | 0.1549 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 17.7407 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 23.7558 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ] | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.